الابحاث

South Egypt Cancer Institute

Assiut University

Department of Radiotherapy and Nuclear medicine
# Title Research Member Research Year
91 Hypofractionation versus conventional radiotherapy
with concurrent Gemcitabine in bladder preservation of
patient with bladder carcinoma 		Prof. Hamza Abbas Hamza Mohammed 2016
92 Pretreatment levels of serum osteoprotegerin and p53 protein
and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients 		Prof. Mohamed Ibrahim Mohamed El-Sayed 2016
93 Role of 18 F-FDG PET/CT in the detection of ovarian cancer recurrence in the setting of normal tumor markers Dr. Yasser Gaber Ali Abdelhafez 2016
94 Role of 18 F-FDG PET/CT in the detection of ovarian cancer recurrence in the setting of normal tumor markers Dr. Yasser Gaber Ali Abdelhafez 2016
95 Excision Repair Cross-Complementation Group 1 (ERCC1): A Prognostic and Predictive Biomarker in Patients with Colorectal Cancer Receiving Adjuvant Oxaliplatin Based Chemotherapy Dr. Shaimaa / Elsayyed Youssef / Ahmed 2016
96 Non-neoplastic variants of the sternum detected on bone scintigraphy using a hybrid SPECT/CT machine Dr. Yasser Gaber Ali Abdelhafez 2016
97 Pretreatment levels of serum osteoprotegerin and p53 protein
and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients 		Prof. Mohamed Ibrahim Mohamed El-Sayed 2016
98 Non-neoplastic variants of the sternum detected on bone scintigraphy using a hybrid SPECT/CT machine Dr. Yasser Gaber Ali Abdelhafez 2016
99 N(2)-L-Alanyl-L-Glutamine Dipeptide Preventing Oxaliplatin-Induced Neurotoxicity in Colorectal Cancer Patients Dr. Shaimaa / Elsayyed Youssef / Ahmed 2016
100 Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumours. Prof. Mohamed Ibrahim Mohamed El-Sayed 2016